In a world where health disparities and access issues persist, decentralized clinical trials are not just an innovation—they are a revolution. By making clinical trials more accessible and inclusive, researchers are paving the way for a future where every individual, regardless of their background, can actively participate in their health journey and contribute to advancing health equity.

Software as a Medical Device (SaMD) is revolutionizing healthcare by improving accessibility, personalization, and equity. Challenges like reimbursement and the digital divide need to be addressed to unlock its full potential for better health outcomes.